MHRA GxP Data Integrity Definitions and Guidance for Industry
The guidance is intended to be a useful resource on the core elements of a compliant data governance system across all GxP sectors (good laboratory practice, good clinical practice, good manufacturing practice, good distribution practice and good pharmacovigilance practice).
It addresses fundamental failures identified by MHRA and international regulatory partners during GLP, GCP, GMP and GDP inspections; many of which have resulted in regulatory action.
The document should be read in conjunction with the applicable regulations and the general guidance specific to each GxP.
We welcome your comments via the which can be emailed to inspectorate@mhra.gsi.gov.uk
Deadline for comments: 31 October 2016
www.gmpviolations.com is the portal where we are publish the multi guidelines and news accross the global operations. The content publised here was owned by their respective country owners.
Posts
0 comments:
Post a Comment